课题基金 / 基金详情

Molecular mechanisms involved in non-apoptotic programmed cell death regulation

Molecular mechanisms involved in non-apoptotic programmed cell death regulation
非凋亡程序性细胞死亡调节的分子机制
批准号:
14580708
负责人:
KITANAKA Chifumi
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

KITANAKA Chifumi的其他基金

相似基金

相关文献

中文摘要
翻译
我们使用Ras依赖的非凋亡程序性细胞死亡的体外模型系统,并解剖参与Ras诱导的非凋亡程序性细胞死亡的调节的分子机制。一般来说,半胱天冬酶非依赖性,非凋亡的程序性细胞死亡是已知的,是依赖于线粒体。因此,我们检查了线粒体是否参与Ras诱导的非凋亡的程序性细胞死亡。我们没有发现Ras诱导的细胞死亡过程中线粒体膜通透性增加的证据,Ras诱导的细胞死亡既不被Bcl-xL也不被vMIA抑制,这是已知的线粒体细胞死亡的有效抑制剂。这些结果表明,Ras诱导的细胞死亡属于一种新的类型的非凋亡的程序性细胞死亡,从来没有报道。利用Ras效应环突变体对Ras激活的细胞内信号通路进行了剖析,揭示了P13 K通路在死亡信号的转导中起着关键作用。筛选抑制或促进Ras诱导的细胞死亡的药理学试剂鉴定艰难梭菌毒素B为Ras诱导的细胞死亡的有效抑制剂,表明Rho蛋白家族可能在Ras诱导的细胞死亡的调节中起重要作用。使用显性负突变体的Rho家族蛋白揭示,Rac等可能有一个关键的作用,Ras诱导的非凋亡程序性细胞死亡。
英文摘要
We used the in vitro model system for Ras-dependent non-apoptotic programmed cell death and dissected the molecular mechanism involved in the regulation of Ras-induced non-apoptotic programmed cell death. In general, caspase-independent, non-apoptotic programmed cell deaths are known to be mitochondria-dependent We therefore examined whether mitochondria is involved in Ras-induced non-apoptotic programmed cell death. We found no evidence of increased permeability of mitochondrial membrane during Ras-induced cell death, and Ras-induced cell death was inhibited neither by Bcl-xL nor by vMIA, which are known to be potent inhitibors of mitochondrial cell death. These results indicated that Ras-induced cell death belongs to a novel type of non-apoptotic programmed cell death that has never been reported. Dissection of the intracellular signaling pathway activated by Ras using Ras effector loop mutant revealed that the Pl3K pathway plays a critical role in the transduction of the death signal. Screening of pharmacological agents that inhibit or promote Ras-induced cell death identified Toxin B of Clostridium difficile as a potent inhibitor of Ras-induced cell death, suggesting that the Rho family of proteins may play an important role in the regulation of Ras-induced cell death. Use of dominant-negative mutants of the Rho family proteins revealed that Rac among others may have a key role in Ras-induced non-apoptotic programmed cell death.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
Sunayama J et al.: "Physical and functional interaction between BH3-only protein Hrk and Mitochondrial pore-forming protein p32."Cell Death and Differentiation. in press. (2004)
Sunayama J 等人:“仅 BH3 蛋白 Hrk 和线粒体成孔蛋白 p32 之间的物理和功能相互作用。”细胞死亡和分化。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Otsuki Y et al.: "Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes with c-Myc-mediated apoptosis in Rat-1 fibroblasts."Journal of Biological Chemistry. 278. 5132-5140 (2003)
Otsuki Y 等人:“鸟嘌呤核苷酸交换因子 Tiam1 直接与 c-Myc 结合并干扰 Rat-1 成纤维细胞中 c-Myc 介导的细胞凋亡。”生物化学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1074/jbc.m206733200
发表时间: 2003-02
期刊: The Journal of Biological Chemistry
影响因子: --
作者: [Y. Otsuki;Masamitsu Tanaka;T. Kamo;C. Kitanaka;Y. Kuchino;H. Sugimura]
通讯作者: Y. Otsuki;Masamitsu Tanaka;T. Kamo;C. Kitanaka;Y. Kuchino;H. Sugimura
Forced expression of antisense 14-3-3beta RNA suppresses tumor growth in vitro and in vivo.
反义 14-3-3β RNA 的强制表达可抑制体外和体内肿瘤生长。
DOI: --
发表时间: 2003
期刊: Carcinogensis 24
影响因子: --
作者: [Sugiyama A et al.]
通讯作者: Sugiyama A et al.
10
    Taking advantage of a pitfall in glioma cancer stem cell epigenetics to develop novel therapies directed to cancer stem cells
    • 批准号:
      16K15640
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      KITANAKA Chifumi
    • 依托单位:
    An attempt to answer the cardinal question --- why do cancer cells have such a sweet tooth? --- through glioma stem cell research
    • 批准号:
      15K15522
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2015
    • 负责人:
      KITANAKA Chifumi
    • 依托单位:
    An attempt to create an animal model for glioblastoma cure via proving the hypothesis that glucose metabolism serves as a rheostat to determine the cell fate of cancer stem cells
    • 批准号:
      26670635
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      KITANAKA Chifumi
    • 依托单位:
    A daring attempt to cure glioblastoma by targeting glucose metabolism as a novel target to control glioma stem cells
    • 批准号:
      25670615
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      KITANAKA Chifumi
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: